Benzinga | Oct 30, 2020 05:13AM EDT

SVB Leerink Maintains Outperform on NuVasive, Lowers Price Target to $65

SVB Leerink maintains NuVasive (NASDAQ:NUVA) with a Outperform and lowers the price target from $70 to $65.